Most cells in the human body exist in complex three-dimensional environments, yet they are still commonly studied on flat plastic dishes. These two-dimensional cultures distort cell behavior, limiting ...
Researchers developed a microfluidic chip with 3D-printed microstructures that moves droplets precisely, captures cells efficiently, and quickly forms cell spheroids for improved lab-grown tissue ...
Digital microfluidics and biochip technologies represent a rapidly evolving interdisciplinary field that integrates principles of physics, chemistry and engineering to manipulate discrete droplets ...
(Nanowerk Spotlight) For decades, microfluidics has held promise as a revolutionary technology, yet widespread adoption outside research labs has remained elusive. Microfluidic devices enable precise ...
CAMBRIDGE, UK & BILLERICA, Mass.--(BUSINESS WIRE)--Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ...
Drug developers are consistently aiming to enhance clinical relevance in drug discovery. CRISPR has emerged as a versatile tool to accelerate the entire drug discovery process, with arrayed CRISPR ...
A research paper by scientists at Beijing Institute of Technology and City University of Hong Kong presented a versatile electrodynamics simulation model designed to analyze the driving forces of ...
Scheme showing the design principle of the DZC-VPP fabrication process. a) Schematic image showing the setup of the DZC-VPP apparatus. b) CAD design of batch printing. c) Photograph of batch printing ...
Understanding cellular heterogeneity is essential for deciphering the complexities of cellular subpopulations, differentiation processes, and microenvironmental influences. Single-cell proteomics ...
Digital SPR TM is a next-generation technology for characterizing biomolecular interactions. By combining digital microfluidics (DMF) with SPR, digital SPR systems can effectively bypass common ...
Global Microfluidic Devices Market to Expand at 9.75% CAGR as Demand for Point-of-Care Testing, Personalized Medicine, and High-Throughput Research Accelerates.Austin, Texas, Jan. 23, 2026 (GLOBE ...